Mao L
Res Sq. 2025; .
PMID: 39975895
PMC: 11838725.
DOI: 10.21203/rs.3.rs-5836301/v1.
Edelmann F, Wachter R, Duvinage A, Mueller S, Fegers-Wustrow I, Schwarz S
Nat Med. 2025; 31(1):306-314.
PMID: 39747684
PMC: 11750725.
DOI: 10.1038/s41591-024-03342-7.
Anderson C, Salvaggio S, De Backer M, Chiem J, Walker G, Saunders D
Adv Radiat Oncol. 2024; 10(1):101674.
PMID: 39678920
PMC: 11638593.
DOI: 10.1016/j.adro.2024.101674.
Huang X, Wang J, Ning J
Stat Med. 2024; 43(30):5922-5934.
PMID: 39582325
PMC: 11645213.
DOI: 10.1002/sim.10282.
Mao L
Clin Trials. 2024; 21(5):584-594.
PMID: 39076157
PMC: 11502278.
DOI: 10.1177/17407745241259356.
Win Statistics in Observational Cancer Research: Integrating Clinical and Quality-of-Life Outcomes.
Chiaruttini M, Lorenzoni G, Spolverato G, Gregori D
J Clin Med. 2024; 13(11).
PMID: 38892983
PMC: 11173121.
DOI: 10.3390/jcm13113272.
Alternative approaches to analyzing ventilator-free days, mortality and duration of ventilation in critical care research.
Serpa Neto A, Bailey M, Shehabi Y, Hodgson C, Bellomo R
Crit Care Sci. 2024; 36:e20240246en.
PMID: 38808905
PMC: 11098075.
DOI: 10.62675/2965-2774.20240246-en.
A hierarchical kidney outcome using win statistics in patients with heart failure from the DAPA-HF and DELIVER trials.
Kondo T, Jhund P, Gasparyan S, Yang M, Claggett B, McCausland F
Nat Med. 2024; 30(5):1432-1439.
PMID: 38710952
PMC: 11108780.
DOI: 10.1038/s41591-024-02941-8.
Win Ratio Analyses of Piperacillin-Tazobactam Versus Meropenem for Ceftriaxone-Nonsusceptible Escherichia coli or Klebsiella pneumoniae Bloodstream Infections: Post Hoc Insights From the MERINO Trial.
Hardy M, Harris P, Paterson D, Chatfield M, Mo Y
Clin Infect Dis. 2024; 78(6):1482-1489.
PMID: 38306577
PMC: 11711476.
DOI: 10.1093/cid/ciae050.
An explainable machine learning-based phenomapping strategy for adaptive predictive enrichment in randomized clinical trials.
Oikonomou E, Thangaraj P, Bhatt D, Ross J, Young L, Krumholz H
NPJ Digit Med. 2023; 6(1):217.
PMID: 38001154
PMC: 10673945.
DOI: 10.1038/s41746-023-00963-z.
Design of a clinical trial using generalized pairwise comparisons to test a less intensive treatment regimen.
De Backer M, Sengar M, Mathews V, Salvaggio S, Deltuvaite-Thomas V, Chiem J
Clin Trials. 2023; 21(2):180-188.
PMID: 37877379
PMC: 11195000.
DOI: 10.1177/17407745231206465.
Power and Sample Size Calculations for the Restricted Mean Time Analysis of Prioritized Composite Endpoints.
Mao L
Stat Biopharm Res. 2023; 15(3):540-548.
PMID: 37663164
PMC: 10473860.
DOI: 10.1080/19466315.2022.2110936.
Rivaroxaban to prevent major clinical outcomes in non-hospitalised patients with COVID-19: the CARE - COALITION VIII randomised clinical trial.
Avezum A, Oliveira Junior H, Neves P, Alves L, Cavalcanti A, Rosa R
EClinicalMedicine. 2023; 60:102004.
PMID: 37223666
PMC: 10194052.
DOI: 10.1016/j.eclinm.2023.102004.
Stratified proportional win-fractions regression analysis.
Wang T, Mao L
Stat Med. 2022; 41(26):5305-5318.
PMID: 36104953
PMC: 9826339.
DOI: 10.1002/sim.9570.
Design and Analysis of Studies Based on Hierarchical Composite Endpoints: Insights from the DARE-19 Trial.
Gasparyan S, Buenconsejo J, Kowalewski E, Oscarsson J, Bengtsson O, Esterline R
Ther Innov Regul Sci. 2022; 56(5):785-794.
PMID: 35699910
PMC: 9196151.
DOI: 10.1007/s43441-022-00420-1.
On recurrent-event win ratio.
Mao L, Kim K, Li Y
Stat Methods Med Res. 2022; 31(6):1120-1134.
PMID: 35345957
PMC: 9246892.
DOI: 10.1177/09622802221084134.
Common scale minimal sufficient balance: An improved method for covariate-adaptive randomization based on the Wilcoxon-Mann-Whitney odds ratio statistic.
Johns H, Italiano D, Campbell B, Churilov L
Stat Med. 2022; 41(10):1846-1861.
PMID: 35176811
PMC: 9303921.
DOI: 10.1002/sim.9332.
Weighted composite time to event endpoints with recurrent events: comparison of three analytical approaches.
Ozga A, Rauch G
BMC Med Res Methodol. 2022; 22(1):38.
PMID: 35123397
PMC: 8818231.
DOI: 10.1186/s12874-022-01511-1.
Statistical models for composite endpoints of death and non-fatal events: a review.
Mao L, Kim K
Stat Biopharm Res. 2021; 13(3):260-269.
PMID: 34540133
PMC: 8442983.
DOI: 10.1080/19466315.2021.1927824.
Sample size formula for general win ratio analysis.
Mao L, Kim K, Miao X
Biometrics. 2021; 78(3):1257-1268.
PMID: 34047366
PMC: 8627514.
DOI: 10.1111/biom.13501.